Cargando…
N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis
Background: Emerging evidence suggests the clinical utility of N terminal pro B type natriuretic peptide (NT-proBNP) in multiple cardiac and pulmonary abnormalities both in adult and pediatric populations. To date, however, there is no consensus regarding its efficacy for the prediction and severity...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532602/ https://www.ncbi.nlm.nih.gov/pubmed/37763055 http://dx.doi.org/10.3390/jpm13091287 |
_version_ | 1785111999433146368 |
---|---|
author | Rodolaki, Kalliopi Pergialiotis, Vasilios Sapantzoglou, Ioakeim Theodora, Marianna Antsaklis, Panagiotis Pappa, Kalliopi Daskalakis, Georgios Papapanagiotou, Aggeliki |
author_facet | Rodolaki, Kalliopi Pergialiotis, Vasilios Sapantzoglou, Ioakeim Theodora, Marianna Antsaklis, Panagiotis Pappa, Kalliopi Daskalakis, Georgios Papapanagiotou, Aggeliki |
author_sort | Rodolaki, Kalliopi |
collection | PubMed |
description | Background: Emerging evidence suggests the clinical utility of N terminal pro B type natriuretic peptide (NT-proBNP) in multiple cardiac and pulmonary abnormalities both in adult and pediatric populations. To date, however, there is no consensus regarding its efficacy for the prediction and severity of bronchopulmonary dysplasia in premature neonates. The objective of the present meta-analysis was to determine differences in NT-proBNP among neonates that develop BPD or die from BPD and to evaluate if there is relative information on the diagnostic accuracy of the method. Methods: We conducted a systematic search according to the PRISMA guidelines and looked into Medline (1966–2023), Scopus (2004–2023), Clinicaltrials.gov (2008–2023), EMBASE (1980–2023), Cochrane Central Register of Controlled Trials CENTRAL (1999–2022) and Google Scholar (2004–2023) together with the reference lists from included studies. The potential risk of bias encountered in our study was evaluated using the QUADAS -2 tool. Finally, a total of 9 studies met the eligibility criteria, comprising 1319 newborns, from which 397 developed BPD and 922 were unaffected controls. Results: The results retrieved from our meta-analysis showed that newborns suffering from BPD had notably elevated NT-proBNP levels after birth when compared with healthy neonates (SMD 2.57, 95% CI 0.41, 4.72). The summary effect of the AUC meta-analysis showed that NT-proBNP was very accurate in detecting neonates at risk of developing severe BPD or dying from the disease (AUC −0.16, 95% CI −0.23, −0.08). No studies reported data relevant to the sensitivity and/or specificity of the method in diagnosing BPD. Conclusion: Serum NT-proBNP levels represent a potential future biomarker with great diagnostic validity for the prediction of BPD complicating preterm deliveries. The limited amount of studies included and the significant variations in cutoff values and timing of measurement still restrict the application of NT-proBNP as an established clinical biomarker for BPD. The design of larger prospective studies will provide a more representative number of participants and will address the discrepancies in existing literature. |
format | Online Article Text |
id | pubmed-10532602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105326022023-09-28 N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis Rodolaki, Kalliopi Pergialiotis, Vasilios Sapantzoglou, Ioakeim Theodora, Marianna Antsaklis, Panagiotis Pappa, Kalliopi Daskalakis, Georgios Papapanagiotou, Aggeliki J Pers Med Systematic Review Background: Emerging evidence suggests the clinical utility of N terminal pro B type natriuretic peptide (NT-proBNP) in multiple cardiac and pulmonary abnormalities both in adult and pediatric populations. To date, however, there is no consensus regarding its efficacy for the prediction and severity of bronchopulmonary dysplasia in premature neonates. The objective of the present meta-analysis was to determine differences in NT-proBNP among neonates that develop BPD or die from BPD and to evaluate if there is relative information on the diagnostic accuracy of the method. Methods: We conducted a systematic search according to the PRISMA guidelines and looked into Medline (1966–2023), Scopus (2004–2023), Clinicaltrials.gov (2008–2023), EMBASE (1980–2023), Cochrane Central Register of Controlled Trials CENTRAL (1999–2022) and Google Scholar (2004–2023) together with the reference lists from included studies. The potential risk of bias encountered in our study was evaluated using the QUADAS -2 tool. Finally, a total of 9 studies met the eligibility criteria, comprising 1319 newborns, from which 397 developed BPD and 922 were unaffected controls. Results: The results retrieved from our meta-analysis showed that newborns suffering from BPD had notably elevated NT-proBNP levels after birth when compared with healthy neonates (SMD 2.57, 95% CI 0.41, 4.72). The summary effect of the AUC meta-analysis showed that NT-proBNP was very accurate in detecting neonates at risk of developing severe BPD or dying from the disease (AUC −0.16, 95% CI −0.23, −0.08). No studies reported data relevant to the sensitivity and/or specificity of the method in diagnosing BPD. Conclusion: Serum NT-proBNP levels represent a potential future biomarker with great diagnostic validity for the prediction of BPD complicating preterm deliveries. The limited amount of studies included and the significant variations in cutoff values and timing of measurement still restrict the application of NT-proBNP as an established clinical biomarker for BPD. The design of larger prospective studies will provide a more representative number of participants and will address the discrepancies in existing literature. MDPI 2023-08-23 /pmc/articles/PMC10532602/ /pubmed/37763055 http://dx.doi.org/10.3390/jpm13091287 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Rodolaki, Kalliopi Pergialiotis, Vasilios Sapantzoglou, Ioakeim Theodora, Marianna Antsaklis, Panagiotis Pappa, Kalliopi Daskalakis, Georgios Papapanagiotou, Aggeliki N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis |
title | N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis |
title_full | N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis |
title_fullStr | N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis |
title_full_unstemmed | N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis |
title_short | N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis |
title_sort | n-terminal pro-b type natriuretic peptide as a predictive biomarker of bronchopulmonary dysplasia or death due to bronchopulmonary dysplasia in preterm neonates: a systematic review and meta-analysis |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532602/ https://www.ncbi.nlm.nih.gov/pubmed/37763055 http://dx.doi.org/10.3390/jpm13091287 |
work_keys_str_mv | AT rodolakikalliopi nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis AT pergialiotisvasilios nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis AT sapantzoglouioakeim nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis AT theodoramarianna nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis AT antsaklispanagiotis nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis AT pappakalliopi nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis AT daskalakisgeorgios nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis AT papapanagiotouaggeliki nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis |